Health regulators on Friday issued draft guidance that would make it easier for pharmaceutical companies to advise doctors about unapproved uses for their medicines.
The Food and Drug Administration proposed letting drugmakers such as Pfizer and Merck distribute medical journal articles to doctors and other health professionals, a controversial area of promotion.
Drug makers by law are prohibited from marketing their drugs for uses not approved by the FDA. But doctors can prescribe drugs for uses beyond approved indications, a practice known as "off-label" use.
Distribution of medical literature suggesting a drug may have merit for a use not yet FDA-approved has been a marketing area in dispute for years.
The public has 60 days to comment on the proposal.
Reuters
Insider's view: Let's get commenting guys!
1 comment:
The FDA has been a pawn of big pharma for decades. Just think... All anyone will ever havbe to do is get approval for any aspect of a treatment and you can market it as a treatment for anything!
SWEET! I'm going to get Nasal Spray approved then market it as an ED treatment. Sure I'll have to fund a couple professors but that's way cheaper than clinical trials!
Post a Comment